Literature DB >> 15286904

[Glaucoma drainage device obstruction].

I Gómez Ledesma1, E Gutiérrez Díaz, M Montero Rodríguez, E Mencía Gutiérrez, I Redondo Marcos.   

Abstract

PURPOSE: To determine the pathophysiology and to discuss possible solutions for tube obstruction since this is a frequent complication in glaucoma drainage device surgery.
MATERIAL AND METHODS: 81 eyes with a glaucoma drainage device (GDD) fitted by our Department during the last twelve years (1991-2002) were retrospectively reviewed and eleven cases of tube obstruction were detected. The treatments included Nd-Yag laser, anterior vitrectomy, blood clot removal and intracamerular rTPA.
RESULTS: The obstruction was proximal in ten cases and distal in one. Of the former, the obstruction was caused by a blood clot in six cases, by vitreous in three cases and by a fibrinous membrane in one case. The nature of the distal obstruction was not determined. One case of vitreous obstruction occurred after a posterior capsulotomy with Nd-Yag laser two years after positioning the GDD. Complete success was achieved in five cases, and partial success in three where antiglaucoma therapy had to be maintained postoperatively. Complete failure was found in the other three cases.
CONCLUSIONS: The material which most frequently caused the tube obstruction was blood and although in some cases this may resolve spontaneously, clot removal with forceps or rTPA intracameral injection may be helpful. In vitreous obstruction, Nd-Yag laser may temporariril clear the tube, but extensive anterior vitrectomy is required to maintain long-term permeability. We suggest carrying out a small posterior capsulotomy in pseudophakic patients with a GDD.

Entities:  

Mesh:

Year:  2004        PMID: 15286904     DOI: 10.4321/s0365-66912004000700008

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  1 in total

1.  Utility of Operative Glaucoma Tube Shunt Viscoelastic Bolus Flush.

Authors:  Sylvia L Groth; Kelsi L Greider; William Eric Sponsel
Journal:  J Curr Glaucoma Pract       Date:  2016-02-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.